Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study
about
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic ReviewA Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future PerspectivesClinical, MRI, and CSF markers of disability progression in multiple sclerosis.The role of advanced magnetic resonance imaging techniques in primary progressive MS.Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MSEvidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosisNovel composite MRI scale correlates highly with disability in multiple sclerosis patients.Can hand dexterity predict the disability status of patients with multiple sclerosis?Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis.Gender issues in multiple sclerosis: an update.Sex disparities in neuro-ophthalmologic disorders.Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.The use of laboratory gait analysis for understanding gait deterioration in people with multiple sclerosis.Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findingsCCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple SclerosisImaging outcome measures for progressive multiple sclerosis trialsSex differences in resting-state functional connectivity in multiple sclerosis.Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients.Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.Brain atrophy and lesion load predict long term disability in multiple sclerosis.Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.Gender-related differences in functional connectivity in multiple sclerosis.Thalamic Damage Predicts the Evolution of Primary-Progressive Multiple Sclerosis at 5 Years
P2860
Q26782408-C6F8D285-306E-4FE2-8EAE-E08ACA8191D2Q28068709-300A41E8-328B-403C-919A-42AF3E6D8E6DQ30712257-F87BF135-13B6-4978-9123-3FA151C12915Q33981654-8DE4F805-3426-49C4-8DF3-F141DB0BD7B6Q34156824-1CFD8F9A-B715-48FF-BA89-571B4BA77523Q34295012-AF5CB875-4E72-4975-95A2-D5619AA5DF24Q34410090-7E65FF8D-427E-4A97-B82E-9A97FF58FC31Q35126308-994CC7E5-C91B-4E2B-B84D-DADF9378B4C2Q35653675-8FA5F207-A497-476A-AF5D-C59BEEEA2245Q36186773-6A680E1D-F84E-4F95-B363-AE487BDE0F5FQ36307718-F057D899-3408-4B9E-B3B5-6534D6B15BA0Q36469295-B65DBE18-9D78-42ED-B945-68078576D9B4Q36475281-9B2B045A-87BE-454B-B8AF-B52133C60BDFQ37813691-0247E3AC-4291-4C83-AC9A-7C74E4FE635AQ38218704-88CAA091-65A2-41C6-8501-D78BABF4051DQ38850911-BA9BB31C-49C0-48D4-8C03-6A45F3D24FD0Q38882438-69C43EAF-C9E0-43A5-8A52-B7F654AE1C48Q40498719-C3E1A502-3FC0-4262-8D7D-E0738CE5FDF6Q40620665-157E91BE-2172-4DF6-8A2B-D19C4062C640Q42660399-80575155-35C6-4186-93DB-740DF98C3C3CQ43647987-2A15F205-9C69-4951-A50B-560ABF38A4B8Q46028716-D02026B6-8894-49F9-876A-FCAAEBC1D968Q46319288-D250BACA-9D9E-4649-B83E-DC388A23656AQ48009677-D43ADC64-4C82-4CFA-B959-BFAAC9E8FEC6Q48112804-1C7D9C19-ED99-4265-8B64-71023D5F2308Q48160589-CC2E6FF5-86BF-4FE8-9A8E-1EE1293CC524Q48384914-C07AE277-27C3-427A-A86F-6CB6C32120BBQ48901292-393EEDCF-8088-41F5-8285-BA907DC1CB2DQ48906222-68982FE7-2160-4023-95E2-FC290158B162Q57911768-60ACBB40-C050-4657-A138-8223B1EE13B4
P2860
Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study
description
im Juni 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 June 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2008
@uk
name
Predicting progression in prim ...... s: A 10-year multicenter study
@en
Predicting progression in prim ...... s: A 10-year multicenter study
@nl
type
label
Predicting progression in prim ...... s: A 10-year multicenter study
@en
Predicting progression in prim ...... s: A 10-year multicenter study
@nl
prefLabel
Predicting progression in prim ...... s: A 10-year multicenter study
@en
Predicting progression in prim ...... s: A 10-year multicenter study
@nl
P2093
P50
P356
P1433
P1476
Predicting progression in prim ...... s: a 10-year multicenter study
@en
P2093
Alex Rovira
Bruno Brochet
Chris Polman
David Miller
Francesco Manfredonia
Frederik Barkhof
Machteld Vellinga
Mara Cercignani
Marco Rovaris
Olga Ciccarelli
P2860
P304
P356
10.1002/ANA.21375
P577
2008-06-01T00:00:00Z